Werewolf Therapeutics Faces Delisting Concerns
Ticker: HOWL · Form: 8-K · Filed: May 15, 2025 · CIK: 1785530
| Field | Detail |
|---|---|
| Company | Werewolf Therapeutics, Inc. (HOWL) |
| Form Type | 8-K |
| Filed Date | May 15, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory-filing
TL;DR
Werewolf Therapeutics might get kicked off the exchange.
AI Summary
Werewolf Therapeutics, Inc. filed an 8-K on May 15, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, with the earliest event reported on May 13, 2025. The company, incorporated in Delaware, is based in Watertown, Massachusetts.
Why It Matters
This filing indicates potential issues with Werewolf Therapeutics' compliance with stock exchange listing requirements, which could lead to the company's shares being delisted.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's stock trading and overall viability.
Key Players & Entities
- Werewolf Therapeutics, Inc. (company) — Registrant
- May 13, 2025 (date) — Earliest event reported
- May 15, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Watertown, Massachusetts (location) — Principal Executive Offices
- 001-40366 (company_id) — SEC File Number
FAQ
What specific listing rule or standard has Werewolf Therapeutics failed to satisfy?
The filing does not specify the exact rule or standard that was not met, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the earliest date associated with the reported event?
The earliest event reported is dated May 13, 2025.
When was this Form 8-K filed with the SEC?
This Form 8-K was filed on May 15, 2025.
Where is Werewolf Therapeutics, Inc. headquartered?
Werewolf Therapeutics, Inc. is headquartered at 200 Talcott Ave, 2nd Floor, Watertown, Massachusetts 02472.
What is the SEC file number for Werewolf Therapeutics, Inc.?
The SEC file number for Werewolf Therapeutics, Inc. is 001-40366.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 15, 2025 regarding Werewolf Therapeutics, Inc. (HOWL).